GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soligenix Inc (STU:DOA) » Definitions » Cyclically Adjusted Book per Share

Soligenix (STU:DOA) Cyclically Adjusted Book per Share : €0.00 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Soligenix Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Soligenix's adjusted book value per share for the three months ended in Mar. 2024 was €0.068. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -86.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -74.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -47.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Soligenix was 41.50% per year. The lowest was -86.50% per year. And the median was -20.40% per year.

As of today (2024-05-24), Soligenix's current stock price is €6.012. Soligenix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.00. Soligenix's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Soligenix was 20.95. The lowest was 0.26. And the median was 1.44.


Soligenix Cyclically Adjusted Book per Share Historical Data

The historical data trend for Soligenix's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soligenix Cyclically Adjusted Book per Share Chart

Soligenix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.46 12.07 6.59 0.38 0.32

Soligenix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.17 -11.45 -4.42 0.32 -

Competitive Comparison of Soligenix's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Soligenix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soligenix's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soligenix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Soligenix's Cyclically Adjusted PB Ratio falls into.



Soligenix Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Soligenix's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.068/131.7762*131.7762
=0.068

Current CPI (Mar. 2024) = 131.7762.

Soligenix Quarterly Data

Book Value per Share CPI Adj_Book
201406 -25.746 100.560 -33.738
201409 -22.571 100.428 -29.617
201412 -0.783 99.070 -1.041
201503 -9.986 99.621 -13.209
201506 -17.835 100.684 -23.343
201509 -2.300 100.392 -3.019
201512 -0.082 99.792 -0.108
201603 -4.509 100.470 -5.914
201606 0.137 101.688 0.178
201609 7.723 101.861 9.991
201612 19.228 101.863 24.875
201703 14.905 102.862 19.095
201706 8.510 103.349 10.851
201709 6.683 104.136 8.457
201712 9.175 104.011 11.624
201803 5.665 105.290 7.090
201806 3.848 106.317 4.769
201809 6.738 106.507 8.337
201812 4.682 105.998 5.821
201903 3.855 107.251 4.737
201906 2.576 108.070 3.141
201909 1.783 108.329 2.169
201912 0.904 108.420 1.099
202003 1.851 108.902 2.240
202006 2.810 108.767 3.404
202009 3.160 109.815 3.792
202012 1.506 109.897 1.806
202103 5.453 111.754 6.430
202106 4.845 114.631 5.570
202109 4.503 115.734 5.127
202112 3.320 117.630 3.719
202203 2.088 121.301 2.268
202206 1.386 125.017 1.461
202209 0.363 125.227 0.382
202212 -0.802 125.222 -0.844
202303 -1.080 127.348 -1.118
202306 0.544 128.729 0.557
202309 0.381 129.860 0.387
202312 0.223 129.419 0.227
202403 0.068 131.776 0.068

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Soligenix  (STU:DOA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Soligenix was 20.95. The lowest was 0.26. And the median was 1.44.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Soligenix Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Soligenix's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Soligenix (STU:DOA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soligenix Inc (STU:DOA) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
29 Emmons Drive, Suite B-10, Princeton, NJ, USA, 08540
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Soligenix (STU:DOA) Headlines

No Headlines